Skip to Main ContentSkip to Footer

Areas of Expertise

  • Breast Reconstructive Surgery
  • Cosmetic Plastic Surgery
  • Hemangiomas
  • Melanoma, Non-Melanoma Skin Cancer
  • Plastic Surgery
  • Plastic and Reconstructive Surgery
  • Post Cancer Reconstructive Surgery
  • Reconstructive Plastic Surgery
  • Skin Cancer Reconstruction

Languages

  • English
  • French
  • Spanish

Education

  • Residency in General Surgery - Hospital General Dr. Manuel Gea Gonzalez, 2009
  • Residency in Plastic and Reconstructive Surgery​ - Universidad Nacional Autonoma de Mexico, 2012
  • Fellowship In Craniomaxillofacial Surgery - International Craniofacial Institute, 2013
  • Fellowship In Pediatric Plastic Surgery - The Royal Children's Hospital Melbourne, 2014
  • Fellowship In Craniomaxillofacial Surgery - University of Tennessee Health Science Center, 2018
  • Fellowship In Craniomaxillofacial Surgery - University of Tennessee Health Science Center, 2019
  • Fellowship In Microsurgery - University of Tennessee Health Science Center, 2020
  • Doctor of Medicine

Patient Comments

Patient Comments are gathered from the Press Ganey Patient Experience Survey and displayed in full. Patients are not identified in order to respect patient privacy.
He is a wonderful doctor.
September 25, 2026
Fantastic care and walking through process and concerns
September 3, 2026
Good experience
September 3, 2026
Dr. Espel was wonderful. A appreciate his bedside manner and efficiency. He performed a minor surgery on me in the office and even called me the next day to check on me. 10/10 recommend.
August 31, 2026
Treated well
August 30, 2026
Good experience
August 19, 2026
Excellent
July 24, 2026
This was was first appointment with Dr. Espel and I found him to be a great doctor. He kept me informed throughout my procedure and answered all my questions.
July 18, 2026
Excellent doctor who totally explained everything about the surgery and also about why it needs to wait for a little while due to the radiation treatment I was told I needed just the day before after the Tumor Board meeting met on Wednesday.
July 10, 2026